Form 8-K - Current report:
SEC Accession No. 0001641172-25-001880
Filing Date
2025-03-31
Accepted
2025-03-31 17:25:02
Documents
14
Period of Report
2025-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35317
2 ex10-1.htm EX-10.1 123634
  Complete submission text file 0001641172-25-001880.txt   360035

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE shph-20250330.xsd EX-101.SCH 3030
4 XBRL LABEL FILE shph-20250330_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE shph-20250330_pre.xml EX-101.PRE 24175
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3813
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 25795165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)